Healthcare

Ansell Ltd (ASX:ANN) attracted investor attention in the latest trading session, with the stock trading at $32.60. The gain reflects continued interest from investors in the healthcare sector, where selected names have benefited from defensive positioning and sector-specific tailwinds. Market attention on Ansell Ltd …

Artrya Ltd (ASX:AYA) attracted investor attention in the latest trading session, with the stock trading at $6.16. The move reflects near-term selling pressure that has weighed on several healthcare sector names amid broader market volatility. Market attention on Artrya Ltd reflects a broader investor …

Cochlear Ltd (ASX:COH) attracted investor attention in the latest trading session, with the stock trading at $127.89. The gain reflects continued interest from investors in the healthcare sector, where selected names have benefited from defensive positioning and sector-specific tailwinds. Market attention on Cochlear Ltd …

CSL Ltd (ASX:CSL) attracted investor attention in the latest trading session, with the stock trading at $124.495. The gain reflects continued interest from investors in the healthcare sector, where selected names have benefited from defensive positioning and sector-specific tailwinds. Market attention on CSL Ltd …

EBR Systems Inc is an Australian company operating in the healthcare sector. The company conducts its activities across relevant projects, operations or service areas consistent with its stated business strategy. As with many companies in this space, EBR Systems Inc's financial performance is influenced …

Beamtree Holdings Ltd is an Australian company operating in the healthcare sector. The company conducts its activities across relevant projects, operations or service areas consistent with its stated business strategy. As with many companies in this space, Beamtree Holdings Ltd's financial performance is influenced …

Clarity Pharmaceuticals operates in the radiopharmaceutical industry, a specialised area of nuclear medicine focused on developing precision diagnostics and targeted cancer therapies. The company is advancing multiple clinical-stage programs aimed at improving cancer detection and treatment through its proprietary Targeted Copper Theranostics (TCT) platform.